2.02
price down icon0.49%   -0.010
 
loading
Schlusskurs vom Vortag:
$2.03
Offen:
$2.06
24-Stunden-Volumen:
47,745
Relative Volume:
0.27
Marktkapitalisierung:
$27.23M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-30.16M
KGV:
-5.9412
EPS:
-0.34
Netto-Cashflow:
$-39.49M
1W Leistung:
-2.42%
1M Leistung:
-3.35%
6M Leistung:
-30.46%
1J Leistung:
-48.99%
1-Tages-Spanne:
Value
$2.01
$2.06
1-Wochen-Bereich:
Value
$2.01
$2.1393
52-Wochen-Spanne:
Value
$1.83
$9.19

Dare Bioscience Inc Stock (DARE) Company Profile

Name
Firmenname
Dare Bioscience Inc
Name
Telefon
858-926-7655
Name
Adresse
3655 NOBEL DRIVE, SAN DIEGO, CA
Name
Mitarbeiter
23
Name
Twitter
@DareBioscience
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
DARE's Discussions on Twitter

Vergleichen Sie DARE mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
DARE
Dare Bioscience Inc
2.02 27.36M 0 -30.16M -39.49M -0.34
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
417.21 108.30B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
652.91 69.37B 14.25B 4.58B 3.56B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
481.59 62.38B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
821.97 51.50B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
166.95 34.94B 398.11M -1.03B -868.57M -5.7032

Dare Bioscience Inc Aktie (DARE) Neueste Nachrichten

pulisher
Oct 06, 2025

Daré Bioscience receives $4 million grant installment for contraceptive device By Investing.com - Investing.com Nigeria

Oct 06, 2025
pulisher
Oct 06, 2025

Daré Bioscience Receives $4 Million Non-Dilutive Grant - GlobeNewswire

Oct 06, 2025
pulisher
Oct 06, 2025

Law Custodial Inc. Files Schedule 13G Showing 1.41M DARE Shares - Stock Titan

Oct 06, 2025
pulisher
Oct 06, 2025

Dare Bioscience (DARE) Secures $4M for Long-Acting Contraceptive Development - GuruFocus

Oct 06, 2025
pulisher
Oct 06, 2025

Daré Bioscience receives $4 million grant installment for contraceptive device - Investing.com India

Oct 06, 2025
pulisher
Oct 06, 2025

Daré Bioscience Receives $4 Million Non-Dilutive Grant Installment; Total of $41.8M Received to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for Contraception; Platform has Broader Application Potential in Obesity and Metabolic - GlobeNewswire

Oct 06, 2025
pulisher
Oct 06, 2025

$41.8M Received to Date — Daré Bioscience Advances DARE-IDDS Contraception Program, Seeks Partners - Stock Titan

Oct 06, 2025
pulisher
Sep 30, 2025

Daré Bioscience enters into $15M stock purchase agreement - MSN

Sep 30, 2025
pulisher
Sep 29, 2025

Dare Bioscience risks Nasdaq delisting over market value - MSN

Sep 29, 2025
pulisher
Sep 24, 2025

DARE Secures Gates Foundation Funding for Preeclampsia Projects - GuruFocus

Sep 24, 2025
pulisher
Sep 24, 2025

Daré Bioscience, Inc. Secures $499,000 Grant from Gates Foundation to Address Preeclampsia in Women's Health - Quiver Quantitative

Sep 24, 2025
pulisher
Sep 24, 2025

Daré Bioscience to Receive up to $499,000 to Support Preeclampsia Research - GlobeNewswire

Sep 24, 2025
pulisher
Sep 24, 2025

76,000 Maternal Deaths Annually: Daré Bioscience Receives Gates Grant to Combat Preeclampsia Crisis - Stock Titan

Sep 24, 2025
pulisher
Sep 21, 2025

Dare Bioscience (NASDAQ:DARE) Shares Pass Below 200 Day Moving Average – What’s Next? - Defense World

Sep 21, 2025
pulisher
Sep 17, 2025

Daré Bioscience targets Q4 2025 launch for DARE to PLAY Sildenafil cream while advancing dual-path strategy - MSN

Sep 17, 2025
pulisher
Sep 15, 2025

Dare Bioscience files to sell 2.75M shares of common stocks by selling shareholders - MSN

Sep 15, 2025
pulisher
Sep 14, 2025

What’s the recovery path for long term holders of Daré Bioscience Inc.Inflation Watch & Low Drawdown Investment Ideas - newser.com

Sep 14, 2025
pulisher
Sep 12, 2025

Using Python tools to backtest Daré Bioscience Inc. strategies2025 Price Action Summary & Comprehensive Market Scan Insights - Newser

Sep 12, 2025
pulisher
Sep 04, 2025

Maxim upgrades Daré Bioscience on extended cash runway, commercial launch - TradingView

Sep 04, 2025
pulisher
Sep 04, 2025

Maxim Group upgrades Dare Bioscience stock to Buy on funding boost - Investing.com Canada

Sep 04, 2025
pulisher
Sep 04, 2025

Dare Bioscience (DARE) Upgraded to Buy by Maxim Group | DARE Sto - GuruFocus

Sep 04, 2025
pulisher
Sep 04, 2025

Dare Bioscience shares rise 4.37% premarket after Maxim upgraded to Buy from Hold. - AInvest

Sep 04, 2025
pulisher
Sep 04, 2025

Dare Bioscience: Maxim Group upgrades Buy from Hold, PT $8. - AInvest

Sep 04, 2025
pulisher
Sep 04, 2025

Maxim Upgrades Dare Bioscience to Buy From Hold, Price Target is $8 - MarketScreener

Sep 04, 2025
pulisher
Sep 04, 2025

This Brinker International Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga

Sep 04, 2025
pulisher
Sep 03, 2025

Daré Bioscience Engages Market with New Presentation - TipRanks

Sep 03, 2025
pulisher
Aug 28, 2025

Daré Bioscience, Inc. (NASDAQ:DARE) Q2 2025 Earnings Call Transcript - MSN

Aug 28, 2025
pulisher
Aug 23, 2025

Pattern recognition hints at Daré Bioscience Inc. upsideQuarterly Trade Review & Long-Term Safe Investment Ideas - Newser

Aug 23, 2025
pulisher
Aug 19, 2025

Brookline Capital Markets Sticks to Their Buy Rating for Daré Bioscience (DARE) - The Globe and Mail

Aug 19, 2025
pulisher
Aug 19, 2025

Dolliver Maintains Buy Rating on Daré Bioscience with $11 Price Target - AInvest

Aug 19, 2025
pulisher
Aug 18, 2025

Dare Bioscience, Inc. (DARE) Reports Q2 Loss, Lags Revenue Estimates - MSN

Aug 18, 2025
pulisher
Aug 18, 2025

Dare Bioscience stock price target lowered to $11 at Brookline Capital - Investing.com Canada

Aug 18, 2025
pulisher
Aug 18, 2025

Daré Bioscience's Strategic Growth and Market Expansion Ahead of Sildenafil Cream Launch - AInvest

Aug 18, 2025
pulisher
Aug 18, 2025

Daré Bioscience: Strategic Growth and Market Expansion with Upcoming Sildenafil Cream Launch - TipRanks

Aug 18, 2025
pulisher
Aug 15, 2025

Dare Bioscience shares fall 3.55% after-hours following Q2 2025 earnings call. - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

Dare Bioscience 2025 Q2 Earnings Net Loss Widens Sharply - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

Dare Bioscience 2025 Q2 Earnings Sharp Net Loss Deteriorates 131% - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

Dare Bioscience Inc (DARE) Q2 2025 Earnings Call Highlights: Strategic Advances and Financial ... - Yahoo Finance

Aug 15, 2025
pulisher
Aug 15, 2025

Daré Bioscience Announces Q2 2025 Financial Results - TipRanks

Aug 15, 2025
pulisher
Aug 14, 2025

Daré Bioscience Q2 2025 Earnings Call: Financial Results and Business Update - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Daré Bioscience's Q2 2025: Diverging Paths in Marketing, Financial Health, and R&D Investment - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Daré Bioscience's Q2 2025 Earnings: A Strategic Inflection Point in Women's Health Innovation - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

Aug 14, 2025
pulisher
Aug 14, 2025

Earnings call transcript: Dare Bioscience Q2 2025 reports cash boost, product updates - Investing.com Canada

Aug 14, 2025
pulisher
Aug 14, 2025

Transcript : Daré Bioscience, Inc., Q2 2025 Earnings Call, Aug 14, 2025 - MarketScreener

Aug 14, 2025
pulisher
Aug 14, 2025

Daré Bioscience Posts Narrower Q2 Loss - The Motley Fool

Aug 14, 2025
pulisher
Aug 14, 2025

Daré Bioscience Readies First Commercial Product Launch as Multiple Women's Health Solutions Near Market - Stock Titan

Aug 14, 2025

Finanzdaten der Dare Bioscience Inc-Aktie (DARE)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$36.67
price up icon 0.71%
$90.18
price down icon 1.60%
$28.95
price down icon 0.62%
$103.35
price down icon 1.60%
biotechnology ONC
$314.85
price down icon 0.63%
$166.95
price up icon 1.00%
Kapitalisierung:     |  Volumen (24h):